258 related articles for article (PubMed ID: 22205737)
21. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
22. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
Zhang J; Jia L; Tsang CM; Tsao SW
Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
[TBL] [Abstract][Full Text] [Related]
23. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
25. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma.
Lei T; Yuen KS; Xu R; Tsao SW; Chen H; Li M; Kok KH; Jin DY
Int J Cancer; 2013 Jul; 133(1):79-87. PubMed ID: 23280823
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Shinozaki A; Sakatani T; Ushiku T; Hino R; Isogai M; Ishikawa S; Uozaki H; Takada K; Fukayama M
Cancer Res; 2010 Jun; 70(11):4719-27. PubMed ID: 20484038
[TBL] [Abstract][Full Text] [Related]
29. STRUCTURAL AND FUNCTIONAL CHARACT ERISTICS OF THE LMP1 ONCOGENE IN PATIENTS WITH TUMORS ASSOCIATED AND NOT ASSOCIATED WITH THE EPSTEIN-BARR VIRUS.
Senyuta NB; Smirnova KV; Diduk SV; Goncharova EV; Shcherbak LN; Gurtsevitch VE
Mol Gen Mikrobiol Virusol; 2016 Sep; 34(2):71-75. PubMed ID: 30380210
[TBL] [Abstract][Full Text] [Related]
30. LMP1-miR-146a-CXCR4 axis regulates cell proliferation, apoptosis and metastasis.
Wang W; Zhang Y; Liu W; Xiao H; Zhang Q; Wang J; Luo B
Virus Res; 2019 Sep; 270():197654. PubMed ID: 31299195
[TBL] [Abstract][Full Text] [Related]
31. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
Cameron JE; Yin Q; Fewell C; Lacey M; McBride J; Wang X; Lin Z; Schaefer BC; Flemington EK
J Virol; 2008 Feb; 82(4):1946-58. PubMed ID: 18057241
[TBL] [Abstract][Full Text] [Related]
33. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
34. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22.
Lung RW; Tong JH; Sung YM; Leung PS; Ng DC; Chau SL; Chan AW; Ng EK; Lo KW; To KF
Neoplasia; 2009 Nov; 11(11):1174-84. PubMed ID: 19881953
[TBL] [Abstract][Full Text] [Related]
35. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C
FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
38. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.
Hsu CY; Yi YH; Chang KP; Chang YS; Chen SJ; Chen HC
PLoS Pathog; 2014 Feb; 10(2):e1003974. PubMed ID: 24586173
[TBL] [Abstract][Full Text] [Related]
39. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
